Basilea Pharmaceutica

This study tests a new medicine called fosmanogepix for treating life-threatening Candida infections in the blood or body. About 450 adults will receive either the new drug or standard treatment. The goal is to see if fosmanogepix works as well as current options and is safe.

This study tests a new medicine called fosmanogepix for adults with serious mold infections that are hard to treat. About 234 people will join, receiving either the new drug or standard care. The main goal is to see if the drug lowers the chance of death within 42 days.

This early-stage study is testing a new antibiotic called BAL2420 in healthy adults to see if it is safe and how the body processes it. The drug is being developed to fight serious bacterial infections that are hard to treat. About 136 volunteers will receive either the drug or a…

This early-stage study tests a new antibiotic combination (ceftibuten-ledaborbactam etzadroxil) in about 46 healthy adults aged 18-55. The goal is to check safety and how the drug moves through the body, not to treat any disease. Results will help decide if further studies are po…